REQUEST A DEMO
Total
USD $0.00
Search more companies

Wanbury Ltd. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Wanbury Ltd. Profile Updated: October 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Wanbury Ltd. is a pharmaceutical company located in Navi Mumbai, India. It is recognized as one of the top 50 companies in India according to ORG-IMS. Wanbury specializes in the sales and marketing of Active Pharmaceutical Ingredients (API) globally, with a presence in over 50 countries. They are the largest manufacturer of Metformin, producing over 8500 tons per year. Wanbury also exports to regulated markets, with 65% of their exports going to these markets. They have two US-FDA approved multi-product API facilities and one plant operating for semi-regulated markets. Wanbury is a preferred supplier to some of the top five generic players in the world. In addition to API, Wanbury has a strong presence in ethical formulations, with a portfolio of close to 70 brands. They cover various medical fields such as gynecology, orthopedics, anti-diabetic, and antibiotics. Wanbury's corporate office is located in Vashi, Navi Mumbai.

Headquarters
BSEL Tech Park, B-Wing,, 10th Floor, Sector 30-A, Opp. Vashi Railway Station
Navi Mumbai; Maharashtra; Postal Code: 400703

Contact Details: Purchase the Wanbury Ltd. report to view the information.

Website: http://www.wanbury.com

Basic Information
Total Employees:
Purchase the Wanbury Ltd. report to view the information.
Outstanding Shares:
Purchase the Wanbury Ltd. report to view the information.
Registered Capital:
Purchase the Wanbury Ltd. report to view the information.
Financial Auditors:
Purchase the Wanbury Ltd. report to view the information.
Incorporation Date:
1988
Key Executives
Purchase this report to view the information.
Vice Chairman & Whole Time Director
Purchase this report to view the information.
Independent and Non Executive Director
Purchase this report to view the information.
Independent and Non Executive Director
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Ind. Non-Executive Woman Director
Ownership Details
Purchase this report to view the information.
40.66%
Purchase this report to view the information.
30.54%
Purchase this report to view the information.
18.54%
Purchase this report to view the information.
9.23%
Purchase this report to view the information.
1.02%
Subsidiaries
Cantabria Pharma SL
100%
Laboratories Wanbury SL
100%
Ningxia Wanbury Fine Chemicals Co.Ltd.
100%
Company Performance
Financial values in the chart are available after Wanbury Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-10.38%
Total operating revenue
-10.38%
Operating profit (EBIT)
-24.31%
EBITDA
-17.69%
Net Profit (Loss) for the Period
-77.83%
Total equity
0.12%
Operating Profit Margin (ROS)
-1.08%
Net Profit Margin
-2.42%
Return on Equity (ROE)
-11.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?